Collectively, the data summarized in Table 1 and new advisable investigations may improve the understanding of both biological involvement and clinical relevance of AR in BC, and encourage a careful examination of the therapeutic potential of an AR-based approach in potentiating the effectiveness of anti-estrogen adjuvant therapies or designing new therapies for estrogen-insensitive neoplasms. The gene discussed is AR; the disease is breast cancer.